Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)

Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial

(2013) Y. Onishi et al.   DIABETES OBESITY & METABOLISM

Patient empowerment and optimal glycemic control

(2012) Russell D. White   CURRENT MEDICAL RESEARCH AND OPINION

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

(2012) B. Zinman et al.   DIABETES CARE

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes

(2012) T. Heise et al.   DIABETES OBESITY & METABOLISM

Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study

(2012) M. Peyrot et al.   DIABETES OBESITY & METABOLISM

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

(2012) M. Peyrot et al.   DIABETIC MEDICINE

Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe

(2012) Rosemarie Lajara et al.   Expert Opinion on Drug Delivery

FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals

(2012) Timothy Bailey et al.   Expert Review of Medical Devices

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

(2012) Alan J Garber et al.   LANCET

Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes

(2012) Jason Yeaw et al.   Diabetes Therapy

Preference for a new prefilled insulin pen compared with the original pen

(2011) S. Garg et al.   CURRENT MEDICAL RESEARCH AND OPINION

Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning

(2011) Daniel A. Nadeau et al.   CURRENT MEDICAL RESEARCH AND OPINION

Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals

(2011) T. Bailey et al.   CURRENT MEDICAL RESEARCH AND OPINION

Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes

(2011) Stuart A. Ross et al.   CURRENT MEDICAL RESEARCH AND OPINION

Standards of Medical Care in Diabetes--2012

(2011)   DIABETES CARE

Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses

(2011) David Oyer et al.   Expert Opinion on Drug Delivery

Factors Associated with Persistence and Resumption of Insulin Pen Use for Patients with Type 2 Diabetes

(2010) Mark Peyrot et al.   Diabetes Technology & Therapeutics

Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy

(2009) Robert E. Rakel   ADVANCES IN THERAPY

Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling Study in patients with type 2 diabetes

(2009) Tanja Reimer et al.   CLINICAL THERAPEUTICS

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETMstudy

(2009) L. Blonde et al.   DIABETES OBESITY & METABOLISM

Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study

(2008) A. Liebl et al.   CURRENT MEDICAL RESEARCH AND OPINION

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial

(2008) M. Davies et al.   DIABETES OBESITY & METABOLISM